Purchases and Sales Made in Q4 2023 in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN) during Q4 2023. The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ashford Capital Management Inc
Wilmington, DE |
SELL
|
- |
-90.3K- 9.85% |
$2.05M - $2.68M
|
826K
$26.7M
|
|
|
Feb 13, 2024
Q4 2023
|
Loomis Sayles & CO L P
|
SELL
|
- |
-93.8K- 5.42% |
$2.13M - $2.78M
|
1.64M
$52.8M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-97.6K- 38.53% |
$2.22M - $2.9M
|
156K
$5.03M
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-99.9K- 43.31% |
$2.27M - $2.96M
|
131K
$4.22M
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-153K- 22.37% |
$3.47M - $4.53M
|
530K
$17.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-166K- 44.09% |
$3.76M - $4.92M
|
210K
$6.78M
|
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-442K- 8.68% |
$10M - $13.1M
|
4.65M
$150M
|
|
|
Feb 14, 2024
Q4 2023
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-566K- 97.4% |
$12.8M - $16.8M
|
15.1K
$488K
|